The Gut Microbiota-Immunity Axis in ALS: A Role in Deciphering Disease Heterogeneity?
Ontology highlight
ABSTRACT: Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder with an unknown etiology and no effective treatment, and is characterized by large phenotypic heterogeneity, including variable sites, ages of symptom onset and rates of disease progression. Increasing data support the role of the microbiota-immunity axis in the pathogenesis of neurodegenerative diseases. In the present study, we compared the inflammatory and microbiota profile of ALS patients with different clinical characteristics, with healthy family caregivers. Measuring a panel of 30 inflammatory cytokines in serum and fecal samples, we observed a distinct cytokine profile both at the systemic and intestinal level in patients compared to controls and even in patients with different clinical phenotypes and progression
SUBMITTER: Niccolai E
PROVIDER: S-EPMC8301418 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA